ArticlePharmacoEconomics2013

Cost-utility analysis of deferiprone for the treatment of β-thalassaemia patients with chronic iron overload: a UK perspective.

Anthony Bentley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.